Literature DB >> 1500186

Effects of gamma interferon on release of tumor necrosis factor alpha from lipopolysaccharide-tolerant human monocyte-derived macrophages.

M Matic1, S R Simon.   

Abstract

After an initial stimulation of human monocyte-derived macrophages with bacterial lipopolysaccharide (LPS), which produces substantial release of tumor necrosis factor-alpha (TNF-alpha), a subsequent exposure to LPS results in about an order-of-magnitude reduction in the levels of TNF-alpha released. We have shown that macrophages which have been stimulated with LPS and then maintained in culture without LPS for as long as 2 weeks do not regain their original capacity to secrete TNF-alpha upon a second LPS challenge. After 2 to 4 days in adherent culture, monocyte-derived macrophages which were not pretreated with LPS also experience a measurable decline in their capacity to release TNF-alpha in response to an initial LPS stimulation. When compared with these previously nonstimulated cells, however, the levels of TNF-alpha released by LPS-pretreated cells in response to a second LPS challenge decline by over 90% after 8 to 9 days in culture. Unstimulated cells spontaneously release barely detectable levels of TNF-alpha. In contrast to the release of TNF-alpha, unstimulated cells release significant levels of prostaglandin E2 continuously over time, and these levels are variably increased by no more than a factor of two in response to a single LPS stimulation. Prostaglandin E2 levels released by LPS-pretreated cells in response to a second LPS stimulation are much closer to the levels released by unstimulated cells. We have also demonstrated that gamma interferon (IFN-gamma) enhances TNF-alpha release from LPS-stimulated macrophages but not from phorbol myristate acetate-stimulated cells. Addition of IFN-gamma to macrophages either during the initial stimulation or during a second stimulation with LPS enhances levels of TNF-alpha released after the second LPS challenge. The greatest enhancement is observed when IFN-gamma is added during both exposures to LPS, but addition of IFN-gamma during only the initial LPS stimulation still results in marked enhancement of TNF-alpha release in response to a second stimulation with LPS 24 h later. If an interval of 2 days of culture in medium alone separates the first and second 24-h LPS stimulations, IFN-gamma enhances TNF-alpha release only when it is included during the second LPS exposure, indicating that, unlike the persistence of endotoxin tolerance, enhancement of TNF-alpha release by IFN-gamma is transient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500186      PMCID: PMC257387          DOI: 10.1128/iai.60.9.3756-3762.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Phorbol esters and calcium ionophore can prime murine peritoneal macrophages for tumor cell destruction.

Authors:  S D Somers; J E Weiel; T A Hamilton; D O Adams
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

2.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay.

Authors:  M D Wewers; D J Herzyk
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

4.  Inhibition of lipopolysaccharide-induced in vitro desensitization by interferon-gamma.

Authors:  J G Haas; N Meyer; G Riethmüller; H W Ziegler-Heitbrock
Journal:  Eur J Immunol       Date:  1990-05       Impact factor: 5.532

5.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Downregulation of tumor necrosis factor expression in the human Mono-Mac-6 cell line by lipopolysaccharide.

Authors:  J G Haas; C Thiel; K Blömer; E H Weiss; G Riethmüller; H W Ziegler-Heitbrock
Journal:  J Leukoc Biol       Date:  1989-07       Impact factor: 4.962

7.  Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor.

Authors:  L Sanchez-Cantu; H N Rode; N V Christou
Journal:  Arch Surg       Date:  1989-12

Review 8.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

9.  The interferon-gamma receptor in human monocytes is different from the one in nonhematopoietic cells.

Authors:  P Orchansky; M Rubinstein; D G Fischer
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

10.  Lymphocyte cooperation is required for amplification of macrophage procoagulant activity.

Authors:  G A Levy; T S Edgington
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  6 in total

1.  IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling.

Authors:  Janice Chen; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

2.  Production of cytokines and PGE2 and cytotoxicity of stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages.

Authors:  C K Ogle; X Guo; J Z Wu; J D Ogle
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

3.  Two distinct regions in the 3' untranslated region of tumor necrosis factor alpha mRNA form complexes with macrophage proteins.

Authors:  Z Hel; E Skamene; D Radzioch
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 4.  Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.

Authors:  Ian Albert Clark
Journal:  Pharmacol Res Perspect       Date:  2022-04

5.  HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages.

Authors:  Mohammed Ghiboub; Jing Zhao; Andrew Y F Li Yim; Ronald Schilderink; Caroline Verseijden; Patricia H P van Hamersveld; Jose M Duarte; Theodorus B M Hakvoort; Iris Admiraal; Nicola R Harker; David F Tough; Peter Henneman; Menno P J de Winther; Wouter J de Jonge
Journal:  Front Immunol       Date:  2020-10-05       Impact factor: 7.561

6.  VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways.

Authors:  Mohamed A ElTanbouly; Evelien Schaafsma; Nicole C Smits; Parth Shah; Chao Cheng; Christopher Burns; Bruce R Blazar; Randolph J Noelle; Rodwell Mabaera
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.